Reduced Use of Antibiotics and Nasal Decongestants with Delmopinol Mouthwash
Author Information
Author(s): Sjödin Torgny, Movert Rolf, Åström Mikael
Primary Institution: Biosurface AB; Faculty of Odontology, Malmö University
Hypothesis
Does the use of a mouthwash containing delmopinol HCl 0.2% reduce the need for concomitant medications like antibiotics and nasal decongestants in patients with gingivitis?
Conclusion
The delmopinol HCl 0.2% solution significantly reduced the use of antibiotics and nasal decongestants in patients with gingivitis.
Supporting Evidence
- Patients using delmopinol 0.2% had a 27% lower number of antibiotic treatments compared to placebo.
- A 41% reduction in antibiotic treatments for respiratory infections was observed in the delmopinol group.
- The delmopinol group had a 53% lower number of nasal decongestant treatments compared to placebo.
Takeaway
Using a special mouthwash can help people with gum disease use fewer medicines for infections and stuffy noses.
Methodology
Data from 8 phase III randomized double-blind studies were analyzed to compare the use of concomitant medications between patients using delmopinol mouthwash and those using placebo.
Potential Biases
Potential bias may arise from the study design and the involvement of the manufacturers in the research.
Limitations
The studies were conducted primarily on patients with gingivitis, which may limit the generalizability of the findings to other populations.
Participant Demographics
Patients aged 18 to 73 years, with about 60% men and 40% women, and a mix of smokers and non-smokers.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website